Review |
The Pharmacological Potential of Mushrooms
Institute of Pharmacy, Ernst-Moritz-Arndt-University Friedrich-Ludwig-Jahn-Strasse 17, 17487 Greifswald, Germany
This review describes pharmacologically active compounds from mushrooms. Compounds and complex substances with antimicrobial, antiviral, antitumor, antiallergic, immunomodulating, anti-inflammatory, antiatherogenic, hypoglycemic, hepatoprotective and central activities are covered, focusing on the review of recent literature. The production of mushrooms or mushroom compounds is discussed briefly.
Keywords: antiatherogenic – antimicrobial – antitumor – basidiomycetes – bioactive compounds
*For reprints and all correspondence: Ulrike Lindequist, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Friedrich-Ludwig-Jahn-Strasse 17, 17487 Greifswald, Germany. Tel: +49-3834-864868; Fax: +49-3834-864885; E-mail: lindequi{at}uni-greifswald.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-Y. Guo, C.-C. Han, and Y.-M. Liu A Contemporary Treatment Approach to Both Diabetes and Depression by Cordyceps sinensis, Rich in Vanadium Evid. Based Complement. Altern. Med., November 30, 2009; (2009) nep201v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. L. Willis, O. S. Isikhuemhen, J. W. Allen, A. Byers, K. King, and C. Thomas Utilizing fungus myceliated grain for molt induction and performance in commercial laying hens1 Poult. Sci., October 1, 2009; 88(10): 2026 - 2032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Visavadiya and A. V. R. L. Narasimhacharya Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats Evid. Based Complement. Altern. Med., June 1, 2009; 6(2): 219 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. Taveira, M. R. C. G. Novaes, M. dos Anjos Reis, and M. F. da Silva Hematologic and Metabolic Effects of Dietary Supplementation with Agaricus sylvaticus Fungi on Rats Bearing Solid Walker 256 Tumor Exp Biol Med, November 1, 2008; 233(11): 1341 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Badole, N. M. Patel, P. A. Thakurdesai, and S. L. Bodhankar Interaction of Aqueous Extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with Glyburide in Alloxan Induced Diabetic Mice Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 159 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, Y. Fukuwatari, K. Okumura, K. Takeda, K.-i. Ishibashi, M. Furukawa, N. Ohno, K. Mori, M. Gao, and M. Motoi Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 205 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsuba, H. Matsuno, M. Sakuma, and Y. Komatsu Phellinus linteus Extract Augments the Immune Response in Mitomycin C-Induced Immunodeficient Mice Evid. Based Complement. Altern. Med., March 1, 2008; 5(1): 85 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Moghaddam, M. M. Farimani, S. Salahvarzi, and G. Amin Chemical Constituents of Dichloromethane Extract of Cultivated Satureja khuzistanica Evid. Based Complement. Altern. Med., March 1, 2007; 4(1): 95 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Tumor Immunity, Autoimmunity and Alloreactive Immunity (III) Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II) Evid. Based Complement. Altern. Med., June 1, 2006; 3(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Elisabetsky and L. Costa-Campos The alkaloid alstonine: a review of its pharmacological properties. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 39 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: The Ultimate Antagonist (I). Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper eCAM benefits from diversity that derives from CAM Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 263 - 265. [Full Text] [PDF]
|
|
E-letters:
Read all E-letters
- Thank You Oxford
- Skylar O Saveland
- Evidence-based Complementary and Alternative Medicine, 13 Dec 2005 [Full text]